Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Summary
This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.
Official title: Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery: A Pilot Randomized-Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-06-01
Completion Date
2028-06-01
Last Updated
2026-01-28
Healthy Volunteers
No
Conditions
Interventions
Aprepitant
Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. Oral aprepitant of 80mg will be administered within an hour of induction for an otological surgery.
Placebo
Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. An oral placebo capsule will be administered within an hour of induction for an otological surgery.
Locations (1)
Jewish General Hospital
Montreal, Quebec, Canada